The abstract is read at the publisher; the summary is JClub's.
In steatotic liver disease, overlapping metabolic and alcohol factors are dynamic over time, and transitions across the spectrum can be missed by static diagnostic thresholds, with misclassification common.
- Why it matters: Static categories and thresholds do not reflect how cardiometabolic risk factors and alcohol exposure fluctuate, risking inaccurate diagnosis and risk stratification.
- What they did: The authors propose an integrated, spectrum-based approach using systematic alcohol screening with objective biomarkers such as phosphatidylethanol, structured cardiometabolic risk evaluation, and non-invasive fibrosis assessment with repeated reassessment.
- The result: A dynamic framework is presented as the most pragmatic path to improve diagnosis, treatment planning, and equitable care delivery, while highlighting a trial-to-real-world gap for pharmacotherapies that exclude concurrent alcohol use.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.